Sign in

CIK 0000310158

  • Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
EIN
221918501
Phone
+1 908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$8,611,875
in 1 filing

Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. DeLuca Richard R. −$8.6M EVP&Pres, Merck Animal Heallth sold 34% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-04 Zachary Jennifer EVP, General Counsel Grant or award · Stock Option (Right to Buy) +82,653 82,653
2021-05-04 Zachary Jennifer EVP, General Counsel Exercise or conversion · Restricted Stock Unit −5,772 0
2021-05-04 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Exercise or conversion +694 $75.98 $53K 2,612.35
2021-05-04 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Shares withheld for taxes −238 $75.98 $18K 2,374.35
2021-05-04 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Grant or award · Stock Option (Right to Buy) +18,367 18,367
2021-05-04 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Grant or award · Restricted Stock Unit +2,369 2,369
2021-05-04 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Exercise or conversion · Restricted Stock Unit −694 0
2021-05-04 DeLuca Richard R. EVP&Pres, Merck Animal Heallth Grant or award · Stock Option (Right to Buy) +82,653 82,653
2021-05-04 Gerberding Julie L. EVP Strat Comm, GI Pub Policy Grant or award · Stock Option (Right to Buy) +39,796 39,796
2021-05-04 Chattopadhyay Sanat Exe V-P & Pres. MMD Grant or award · Stock Option (Right to Buy) +85,714 85,714
2021-05-04 Clyburn Frank EVP, Chief Commercial Officer Exercise or conversion +1,906 $75.98 $145K 95,287.06
2021-05-04 Clyburn Frank EVP, Chief Commercial Officer Shares withheld for taxes −939 $75.98 $71K 94,348.06
2021-05-04 Clyburn Frank EVP, Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +131,633 131,633
2021-05-04 Clyburn Frank EVP, Chief Commercial Officer Exercise or conversion · Restricted Stock Unit −1,906 0
2021-05-04 Davis Robert M President Grant or award · Stock Option (Right to Buy) +281,633 281,633
2021-05-04 FRAZIER KENNETH C Chairman & CEO Grant or award · Stock Option (Right to Buy) +329,082 329,082
2021-05-03 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Exercise or conversion +437 $74.50 $33K 2,068.35
2021-05-03 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Shares withheld for taxes −150 $74.50 $11K 1,918.35
2021-05-03 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Exercise or conversion · Restricted Stock Unit −437 439
2021-05-03 Litchfield Caroline EVP & CFO Exercise or conversion +750 $74.50 $56K 19,544.12

Page 44 of 52 · 1,021 trades